Skip to main content
Clinical Trials/NCT00022867
NCT00022867CompletedPhase 1

Optimization of Calcium Absorption and Bone Formation During Early Puberty

Baylor College of Medicine1 site in 1 country100 target enrollmentStarted: May 1, 2001Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
100
Locations
1

Study Overview

Brief Summary

Increasing bone mass during puberty can ultimately decrease the risk of developing osteoporosis, which causes bones to weaken and break more easily later in life. The purpose of this study is to compare calcium absorption and bone growth in boys and girls on diets including either a nondigestible oligosaccharide (NDO) or simple sugar.

Detailed Description

Rapid increases in bone mass occur during calcium absorption and bone calcium deposition during puberty, and these increases can enhance peak bone mass and ultimately decrease the lifetime risk of osteoporosis. However, dietary, hormonal, and genetic factors likely affect increased bone mass. This study will examine if adding NDO to a pubertal diet allows more absorption of calcium by the body, producing stronger bones. The study will also assess how the hormones produced by the body during puberty affect bone growth and whether genetic factors affect calcium absorption or bone growth.

This study will last 2 years. At study entry, baseline pubertal hormone levels and bone mass will be assessed. Both a dual-energy X-ray absorptiometry (DEXA) scan and a calcium stable kinetic study measuring calcium absorption will be performed. Participants will then be randomly assigned to receive calcium fortified food with or without added NDO for 1 year. Calcium absorption will be measured again at 2 months. After the first year, calcium kinetic, hormonal, and DEXA studies will be performed and compared to baseline results. A final DEXA scan will be performed at the end of 2 years.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double

Eligibility Criteria

Ages
9 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Tanner Stage 2 or 3
  • •Girls must not have started menstruating
  • •In the 10th to 90th percentile in body mass index (BMI) for their age

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Steve Abrams, MD

Professor

Baylor College of Medicine

Study Sites (1)

Loading locations...

Similar Trials